-
Coordinator and PI of a “National Facility Project Proposal “National Centre for Screening of Natural Products for Parasitic diseases” supported by Department of Science and Technology under Drugs and Pharmaceuticals Research Program (DPRP), 2019-2022. The centre has collaboration with IICT, Hyderabad and has signed an MOU with Emcure Pharmaceuticals Limited (EPL), Hinjwadi Pune – 411057, India.
-
Department of Science and Technology (DST)
"Identification of Novel Epigenetic Regulators of both Leishmania and of Host after Infection" 2018-2021
-
Israel Science Foundation-UGC-
“Aminoacid sensors in Leishmania donovani” 2016-2018 with no cost extension till December 2019.
-
Department of Science and Technology (DST)
J C Bose Fellow Grant 2016-till the age of 68 years
-
Dr. A.S. Paintal Distinguished Scientist Chair of ICMR grant 2018-2023
-
BSR-UGC Faculty Grant 2017-May 2018
-
Israel Science Foundation-UGC
"Aminoacid sensors in Leishmania donovani" 2016-2018
-
Department of Biotechnology (DBT)
"Genome-wide characterization of tRNA synthetases and their Paralogs from Leishmania" 2013-2016
-
Department of Science and Technology (DST)
"Modulation of Global changes in host cell by Intracellular pathogen Leishmania donovani" 2013-2016
-
Council of Scientific and Industrial Research (CSIR)
R.Madhubala, P.I., 37(1511)/11/EMR-II "Characterization of Vitamin C biosynthesis pathway as a drug target in Leishmania donovani," 2012-2015
-
Department of Biotechnology (DBT)
Centre for Excellence BT/01/CEIB/11/V/08 "Programme support on Molecular Parasitology," 2011-2016
-
Centre for Excellence in Molecular Parasitology, Department of Biotechnology, 2011-2016
-
Indo-Russian Project 2010-2012
Development of novel lead compounds for antimonial resistant Leishmania donovani Role PI
-
Department of Biotechnology (DBT) 2009-2012
Visceral leishmaniasis: Identification and validation of biomarkers for antimony susceptibility/ resistance in clinical isolates of Leishmania donovani Role: PI
-
Life Science Research Board Grant (LSRB) from DRDO
A ubiquitin-conjugated-Leishmanial gene (ORFF) as a DNA vaccine against both antimonial-susceptible and -resistant strains of L. donovani 2008-2011. Role: PI
-
Council of scientific and Industrial Research 2008-2011
Characterization of Hypusine pathway in L. donovani
Role: PI
-
Indo-Swiss Joint Research Propgramme (ISJRP) 2009-2010
Evaluation of drug resistance in Leishmania donovani by Implementing a novel Cell Death assay.
-
Global Infectious Diseases training grant from National Institute of Health, USA 2006-2012
Director: Ken Stuart, USA. Co-director: Marilyn Parsons, Role: Co-director http://www.sbri-india-gid.org/home/workshop.asp
-
Department of Science and Technology project 2005-2008
Role: PI Functional characterization of Leishmania genes by tetracycline-responsive repressor/operator system.
-
Council of scientific and Industrial Research 2005-2008
Role: PI Polyamine biosynthetic enzymes as drug targets in Leishmania donovani,
-
Institute of One World Health Grant (iOWH, San Fransisco, USA) 2006-2008
Role: PI Characterization of the molecular mechanisms of paromomycin transport in Leishmania donovani and determination of the paromomycin sensitivity of visceral leishmaniasis clinical isolates
-
University of Excellence grant:2002-2007
Role: PI Functional genomics of Leishmania. The project involves identification of stage specific genes of Leishmania donovani and characterizing them.
-
Swedish Research Council grant: 2003-2007
Role: Co-PI PI- Lo Persson and Olle Heby, Sweden Structure based drug development against malaria and leishmaniasis under Swedish Research Link Programme. Extension granted for one year.
-
The Wellcome Trust Award: 2002-2005 Joint project with Mike Barrett, Glasgow.
Role PI Molecular and Biochemical mechanisms of Pentamidine resistance
-
UNICEF/UNDP/WORLD BANK/WHO Special Programme for Research and Training in Tropical Diseases (TDR): Jointly with Richard Burchmore, Glasgow, 2005 Role Co PI. A comparative proteomic analysis of pentamidine resistance in Leishmania donovani.
-
Canadian Institute of Health Research Grant (CIHR) Mechanism of antimony drug resistance in Leishmania, Jointly with Marc Ouellette, 2005-2006 Role Co-PI
